Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.49M Sell
15,157
-1,387
-8% -$475K 0.55% 43
2026
Q1
$5.82M Sell
16,544
-326
-2% -$116K 0.66% 31
2025
Q4
$5.52M Buy
16,870
+6,535
+63% +$2.07M 0.63% 33
2025
Q3
$2.92M Buy
10,335
+801
+8% +$232K 0.36% 69
2025
Q2
$2.66M Buy
9,534
+230
+2% +$65.2K 0.37% 68
2025
Q1
$2.9M Buy
9,304
+338
+4% +$99.8K 0.46% 56
2024
Q4
$2.34M Sell
8,966
-88
-1% -$26.1K 0.37% 63
2024
Q3
$2.92M Buy
9,054
+64
+0.7% +$20.9K 0.46% 55
2024
Q2
$2.92M Buy
8,990
+7,013
+355% +$2.06M 0.48% 50
2024
Q1
$562K Sell
1,977
-11
-0.6% -$3.22K 0.1% 190
2023
Q4
$591K Sell
1,988
-87
-4% -$23.7K 0.12% 177
2023
Q3
$558K Sell
2,075
-18
-0.9% -$4.49K 0.13% 173
2023
Q2
$471K Buy
2,093
+99
+5% +$23K 0.1% 196
2023
Q1
$482K Sell
1,994
-21
-1% -$5.16K 0.11% 189
2022
Q4
$514K Buy
2,015
+292
+17% +$78.3K 0.12% 189
2022
Q3
$388K Sell
1,723
-50
-3% -$12.1K 0.11% 183
2022
Q2
$435K Sell
1,773
-4
-0.2% -$980 0.11% 170
2022
Q1
$450K Sell
1,777
-172
-9% -$39.5K 0.1% 193
2021
Q4
$444K Sell
1,949
-625
-24% -$132K 0.1% 196
2021
Q3
$535K Buy
2,574
+475
+23% +$109K 0.12% 165
2021
Q2
$478K Sell
2,099
-12
-0.6% -$2.95K 0.11% 183
2021
Q1
$530K Sell
2,111
-112
-5% -$26.7K 0.13% 151
2020
Q4
$552K Buy
2,223
+144
+7% +$33.2K 0.16% 133
2020
Q3
$480K Buy
2,079
+3
+0.1% +$743 0.18% 117
2020
Q2
$536K Sell
2,076
-109
-5% -$24.9K 0.21% 105
2020
Q1
$456K Sell
2,185
-37
-2% -$8.08K 0.24% 106
2019
Q4
$537K Sell
2,222
-166
-7% -$36.6K 0.21% 127
2019
Q3
$479K Sell
2,388
-903
-27% -$173K 0.21% 129
2019
Q2
$612K Sell
3,291
-128
-4% -$22.9K 0.28% 109
2019
Q1
$594K Sell
3,419
-451
-12% -$86.1K 0.27% 104
2018
Q4
$802K Sell
3,870
-102
-3% -$19.9K 0.37% 80
2018
Q3
$823K Sell
3,972
-8
-0.2% -$1.58K 0.38% 78
2018
Q2
$735K Buy
3,980
+1,977
+99% +$350K 0.36% 87
2018
Q1
$345K Sell
2,003
-5,919
-75% -$1.09M 0.18% 148
2017
Q4
$1.38M Buy
+7,922
New +$1.4M 0.7% 42

Other funds holding AMGN

180 Wealth Advisors's AMGN Position: Q2 2026 in Review

180 Wealth Advisors reduced its Amgen (AMGN) stake by 8.4% in Q2 2026, selling an estimated $475K and leaving 15,157 shares worth $5.49M. The position accounts for 0.55% of the portfolio, ranked #43.

180 Wealth Advisors first reported a position in AMGN in Q4 2017 and has held it in 35 quarters since. The position peaked at $5.82M in Q1 2026. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • 180 Wealth Advisors held 15,157 shares of Amgen worth $5.49M as of Q2 2026.
  • 180 Wealth Advisors sold 1,387 Amgen shares in Q2 2026, an estimated $475K.
  • Amgen made up 0.55% of 180 Wealth Advisors's portfolio in Q2 2026, its #43 holding.
  • 180 Wealth Advisors first reported a position in Amgen in Q4 2017 and has held it in 35 quarters since.
  • 180 Wealth Advisors's Amgen position peaked at $5.82M in Q1 2026.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.